Anti-P53 Antibody (ARG55736)

Product datasheet [email protected]

ARG55736 Package: 100 μg, 50 μg anti-p53 antibody Store at: -20°C

Summary

Product Description Goat Polyclonal antibody recognizes p53

Tested Reactivity Hu, Ms, Rat, Dog, Mk

Tested Application ICC/IF, WB

Specificity Detects P53 by Western blot in transfected cells with GFP-P53.

Host Goat

Clonality Polyclonal

Isotype IgG

Target Name p53

Antigen Species Human

Immunogen Recombinant peptide around aa. 280 (C-terminus) of Human P53

Conjugation Un-conjugated

Alternate Names TRP53; LFS1; Cellular tumor antigen p53; Phosphoprotein p53; Tumor suppressor p53; BCC7; Antigen NY-CO-13; P53

Application Instructions

Application table Application Dilution

ICC/IF 1:50-1:250

WB 1:500-1:2000

Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Calculated Mw 44 kDa

Properties

Form Liquid

Purification Affinity purification with immunogen.

Buffer PBS, 0.05% Sodium azide and 20% Glycerol

Preservative 0.05% Sodium azide

Stabilizer 20% Glycerol

Concentration 3 mg/ml

Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/3 Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation Gene Symbol TP53 Gene Full Name tumor protein p53 Background p53 is a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons from identical transcript variants (PMIDs: 12032546, 20937277). [provided by RefSeq, Dec 2016] Function p53 acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro- apoptotic activity is activated via its interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 (PubMed:12524540). However, this activity is inhibited when the interaction with PPP1R13B/ASPP1 or TP53BP2/ASPP2 is displaced by PPP1R13L/iASPP (PubMed:12524540). In cooperation with mitochondrial PPIF is involved in activating oxidative stress-induced necrosis; the function is largely independent of transcription. Induces the transcription of long intergenic non-coding RNA p21 (lincRNA-p21) and lincRNA- Mkln1. LincRNA-p21 participates in TP53-dependent transcriptional repression leading to apoptosis and seems to have an effect on cell-cycle regulation. Implicated in Notch signaling cross-over. Prevents CDK7 kinase activity when associated to CAK complex in response to DNA damage, thus stopping cell cycle progression. Isoform 2 enhances the transactivation activity of isoform 1 from some but not all TP53-inducible promoters. Isoform 4 suppresses transactivation activity and impairs growth suppression mediated by isoform 1. Isoform 7 inhibits isoform 1-mediated apoptosis. Regulates the circadian clock by repressing CLOCK-ARNTL/BMAL1-mediated transcriptional activation of PER2 (PubMed:24051492). [UniProt] Highlight Related products: p53 antibodies; p53 ELISA Kits; p53 Duos / Panels; p53 recombinant proteins; Anti-Goat IgG secondary antibodies; Related news: Therapeutic strategies against PDAC Senescence Marker Antibody Panel is launched

Images

ARG55736 anti-p53 antibody WB image

Western blot: 50 µg of HaCat and SRA lysates stained with ARG55736 anti-p53 antibody at 1:2500 dilution.

www.arigobio.com 2/3 ARG55736 anti-p53 antibody ICC/IF image

Immunocytochemistry: Hepa1-6 cells stained with ARG55736 anti- p53 antibody at 1:50 dilution. Cell were fixed with methanol.